220 related articles for article (PubMed ID: 7854368)
1. [Correlation between resistance testing and typing of Candida albicans--isolates from AIDS patients and chronic recurrent oral candidiasis].
Ruhnke M; Tennagen I; Engelmann E
Mycoses; 1994; 37 Suppl 1():60-3. PubMed ID: 7854368
[TBL] [Abstract][Full Text] [Related]
2. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
Maninder J; Usha A
J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
[TBL] [Abstract][Full Text] [Related]
3. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of the change in resistance patterns and genetic relationship of oral Candida albicans from HIV-infected patients.
McCullough M; Hume S
J Med Vet Mycol; 1995; 33(1):33-7. PubMed ID: 7650576
[TBL] [Abstract][Full Text] [Related]
5. Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model.
Reynes J; Mallie M; Ravisse P; Bastide JM
J Med Vet Mycol; 1992; 30(5):363-7. PubMed ID: 1469537
[TBL] [Abstract][Full Text] [Related]
6. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
[TBL] [Abstract][Full Text] [Related]
7. Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
Nébavi F; Arnavielhe S; Le Guennec R; Ménan E; Kacou A; Combe P; Aoussi E; Mallié M; Koné M; Bastide JM
Pathol Biol (Paris); 1998 May; 46(5):307-14. PubMed ID: 9769890
[TBL] [Abstract][Full Text] [Related]
8. Biotypes and randomly amplified polymorphic DNA (RAPD) profiles of subgingival Candida albicans isolates in HIV infection.
Pizzo G; Giammanco GM; Pecorella S; Campisi G; Mammina C; D'Angelo M
New Microbiol; 2005 Jan; 28(1):75-82. PubMed ID: 15782629
[TBL] [Abstract][Full Text] [Related]
9. Oral Candida albicans isolates with reduced susceptibility to fluconazole in Swedish HIV-infected patients.
Chryssanthou E; Torssander J; Petrini B
Scand J Infect Dis; 1995; 27(4):391-5. PubMed ID: 8658076
[TBL] [Abstract][Full Text] [Related]
10. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection.
Ruhnke M; Eigler A; Tennagen I; Geiseler B; Engelmann E; Trautmann M
J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Candida albicans isolates from the oral cavity of HIV-positive patients.
Woldeamanuel Y; Abate D
Ethiop Med J; 1998 Oct; 36(4):235-43. PubMed ID: 11957299
[TBL] [Abstract][Full Text] [Related]
12. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
[TBL] [Abstract][Full Text] [Related]
13. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
[TBL] [Abstract][Full Text] [Related]
14. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
[TBL] [Abstract][Full Text] [Related]
15. Synergism of voriconazole and terbinafine against Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Weig M; Müller FM
Antimicrob Agents Chemother; 2001 Mar; 45(3):966-8. PubMed ID: 11181393
[TBL] [Abstract][Full Text] [Related]
16. [Adherence of isolated Candida albicans strains from HIV+ infected patients to buccal epithelial cells: correlation with serotype, sensitivity to fluconazole and virulence].
Imbert-Bernard C; Valentin A; Reynes J; Mallié M; Bastide JM
Pathol Biol (Paris); 1994 Jun; 42(6):567-73. PubMed ID: 7854856
[TBL] [Abstract][Full Text] [Related]
17. Distribution of Candida species among HIV-positive patients with oropharyngeal candidiasis in Accra, Ghana.
Kwamin F; Nartey NO; Codjoe FS; Newman MJ
J Infect Dev Ctries; 2013 Jan; 7(1):41-5. PubMed ID: 23324819
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of the sensitivity to antifungal agents of clinical isolates of Candida albicans serotype A and B by the ATB Fungus method].
Quindós G; San Millán R; Burgos A; Lipperheide V; Tellaetxe M; Alonso R; Barturen B; Pontón J
Enferm Infecc Microbiol Clin; 1995 Apr; 13(4):209-12. PubMed ID: 7779872
[TBL] [Abstract][Full Text] [Related]
20. Molecular aspects of fluconazole resistance development in Candida albicans.
Franz R; Ruhnke M; Morschhäuser J
Mycoses; 1999; 42(7-8):453-8. PubMed ID: 10546486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]